0000899243-18-017972.txt : 20180625 0000899243-18-017972.hdr.sgml : 20180625 20180625182015 ACCESSION NUMBER: 0000899243-18-017972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Jeffrey Allen CENTRAL INDEX KEY: 0001500210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 18917925 MAIL ADDRESS: STREET 1: KING PHARMACEUTICALS, INC. STREET 2: 501 FIFTH STREET CITY: BRISTOL STATE: TN ZIP: 37620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-21 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001500210 Bailey Jeffrey Allen C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 6.02 2018-06-21 4 A 0 10000 0.00 A 2028-06-20 Common Stock 10000 10000 D This option was granted on June 21, 2018. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 21, 2019 or (ii) the date of the Issuer's 2019 Annual Meeting of Stockholders. /s/ Donald Dougherty, attorney-in-fact for Jeffrey Allen Bailey 2018-06-25